The invention relates to novel tetrahydroisoquinoline compounds that are selective estrogen receptor downregulators (SERDs). The present invention also relates to pharmaceutical compositions comprising one or more of the compounds as an active ingredient, and to the use of the compounds in the treatment of estrogen receptor (ER) mediated or dependent diseases or conditions, for example cancer such as breast cancer.
该发明涉及新型
四氢异喹啉化合物,其为选择性
雌激素受体下调调节剂(
SERDs)。本发明还涉及包含一种或多种该化合物作为活性成分的药物组合物,以及利用该化合物治疗
雌激素受体(ER)介导或依赖的疾病或症状,例如乳腺癌等癌症。